Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04984655 · ClinicalTrials.gov registry record · NA
Virtual Reality Experience for Stress Reduction in Cardiology Patients
A NA study of Stress and Blood Pressure, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04984655: Completed NA study of Stress and Blood Pressure, sponsored by University of California, Los Angeles.
NCT04984655 is a NA study of Stress and Blood Pressure that has completed, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04984655, a NA study of Stress and Blood Pressure, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to evaluate the feasibility and scalability of delivering a 30-minute novel virtual reality (VR) experience through the Oculus Quest 2 Virtual Reality headset with the aim of measuring changes in: 1) patient-reported stress levels on a survey, 2) blood pressure, 3)heart rate, 4) respiration rate 5) heart rate variability 6) and galvanic skin response in cardiology clinic and cardiac rehabilitation patients.
Conditions Studied
Interventions
- DEVICE 30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset
Study Locations (1)
California
- Clinical and Translational Research Center, 10833 Le Conte suite BE144 - CHS building - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-12-13 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
What the finished NCT04984655 record still lists
NCT04984655 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which 30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset is the first listed.
NCT04984655 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04984655 about?
NCT04984655 is a clinical study titled "Virtual Reality Experience for Stress Reduction in Cardiology Patients". The purpose of the research is to evaluate the feasibility and scalability of delivering a 30-minute novel virtual reality (VR) experience through the Oculus Quest 2 Virtual Reality headset with the aim of measuring changes in: 1) patient-reported stress levels on a survey, 2) blood pressure, 3)hear...
What is the current status of trial NCT04984655?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-12-13. Estimated completion is 2022-12-01.
What conditions does trial NCT04984655 study?
This clinical trial studies the following conditions: Stress, Blood Pressure, Virtual Reality, Prevention.
What interventions are being tested in trial NCT04984655?
The interventions under investigation include: 30-minute Virtual Reality (VR) Experience delivered through Oculus Quest 2 VR headset (DEVICE).
Who is sponsoring clinical trial NCT04984655?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04984655 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04984655's enrollment target sits among peer trials
20 142nd of 152 higher than 8 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI